Dong Lyu

1 week ago | onlinelibrary.wiley.com | Dong Lyu |Jing Zhao |Hai Jin |Bin Lyu

1 Introduction Gastric cancer (GC) is one of the most common tumors in the gastrointestinal (GI) tract in China. It ranks as the fifth most common cancer and the third leading cancer-related cause of death globally in 2018 [1]. The 5-year survival rate of patients with GC has been estimated to be less than 50%; however, that of early gastric cancer (EGC) after resection is > 90% [2]. Therefore, early detection and treatment of GC is vital in clinical practice.

Nov 7, 2024 | bloomberg.com | Nicholas Takahashi |Dong Lyu

Shiseido Co. slashed its profit outlook for the year as the Japanese cosmetics giant reported a plunge in net income amid a persistent slump in the key Chinese market. Shiseido reported a 26% decline in core operating profit over the first nine months of this year. Net income in the third quarter came in at 739 million yen ($4.8 million), much lower than the 13.4 billion yen average analyst estimate compiled by Bloomberg.

Nov 7, 2024 | bnnbloomberg.ca | Nicholas Takahashi |Dong Lyu

(Bloomberg) -- Shiseido Co. slashed its profit outlook for the year as the Japanese cosmetics giant reported a plunge in net income amid a persistent slump in the key Chinese market. Shiseido reported a 26% decline in core operating profit over the first nine months of this year. Net income in the third quarter came in at 739 million yen ($4.8 million), much lower than the 13.4 billion yen average analyst estimate compiled by Bloomberg.

Jan 15, 2024 | bloomberg.com | John Liu |Dong Lyu

China rolled out a plan for a so-called “silver economy” estimated to be worth trillions of dollars, catering to a rapidly-aging population needing services ranging from meal delivery to nursing homes and entertainment options. Beijing wants to mobilize state and the private sector companies, it said in an outline released by the State Council. They’ll be encouraged to tailor consumer products like clothes, vehicles and food to the specific needs of older people, the paper said.

Dec 26, 2023 | news.bloomberglaw.com | John Liu |Dong Lyu

AstraZeneca Plc agreed to acquire Chinese cell therapy developer <-rte-company state="{"_id":"0000018c-a556-d3fa-abbe-bf7e9f490001","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">Gracell Biotechnologies Inc.-rte-company> for as much as $1.2 billion as the British drug giant bolsters its bets on medical innovation in the world’s second-biggest economy. Under the agreement, Astra will acquire Shanghai-based Gracell for $2 a share, amounting to an upfront cash payment of $1 billion.